Search Results
Results found for "positive allosteric modulators"
- Dr. Antony A. Boucard Jr | Dr. GPCR Ecosystem
proteins expressed as various alternatively spliced isoforms thus potentially resulting in differential modulation
- Trainee Symposium II
engineering, receptor pharmacology, and structural biology to study how different types of ligands modulate
- Dr. Thomas P. Sakmar | Dr. GPCR Ecosystem
strategies to express, reconstitute and assay engineered GPCRs using the visual pigment rhodopsin as a model that stemmed from this work, such as the concept of “functional micro-domains” and the “helix movement model Tom’s lab also pioneered the early use of computational homology modeling, molecular dynamics simulations
- Join the Dr. GPCR Affiliate Program - Empower the GPCR Community with Dr. GPCR Ecosystem Services
A GPCR background is mandatory independent of your current position and industry.
- Revvity | Dr. GPCR Ecosystem
In the following years, he held several marketing and strategic positions in France and the US, primarily All four formats are validated in well-established models like GLP1R and Mu opioid receptor (MOR), and
- Xylazine, Fentanyl, and the Fight for Breath with Catherine Demery | Dr. GPCR Ecosystem
From her early doubts to designing preclinical models of fentanyl and xylazine overdose, she reflects The methods used to measure respiratory depression in live models. shut down breathing through different mechanisms—work that blends receptor pharmacology, preclinical models
- encoding and decoding selectivity and promiscuity in the human chemokine GPCR interaction network | Dr. GPCR Ecosystem
unstructured regions ♦️ Includes a web tool + viral chemokine engineering demo This is a must-read for GPCR modelers
- Dr. GPCR Community Presentation | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
the molecular mechanisms of adhesion GPCRs (aGPCRs) in lymphatic endothelial cells (LECs), a cellular model
- terrys corner from data to insight | Dr. GPCR Ecosystem
The model behind the data 💡 Terry Kenakin shows how experimental snapshots can reveal much more—and drug discovery. 🟢 Built for pharmacologists building stronger pipelines and those rethinking legacy models
- Finance is Science too: How Numbers Keep the Lights On with Chuck DeWeese & Joe St. Germain | Dr. GPCR Ecosystem
The Joy of Building with Purpose Joe’s personal mission— to make a positive impact on people’s lives
- Leadership, Impact, and GPCR Signaling with Dr. Michelle Halls | Dr. GPCR Ecosystem
Why receptor localization and scaffolding dramatically shift functional readouts in disease models. validation under real experimental constraints, Tried to map signaling heterogeneity in disease-relevant models
- Using food perception and bioamine signaling networks to slow aging
The lab works with multiple models, including Caenorhabditis elegans, in vitro tissue culture, and mice
- GPCR Retreat 2023 | Dr. GPCR Ecosystem
science is an intense and interactive experience, and a great training environment for our students and post-doctoral University in Australia, one of the pioneers in the medicinal chemistry, computational and mathematical modelling scientists working in the arenas of structure and signaling, neuroscience, cancer, translational and model organized two trainee symposiums to acknowledge formally the participation of our graduate students and post-doctoral
- 📢 All 2025 Dr.GPCR Courses Are Open for Registration! Which one will you choose? 🚀 Whether you're diving into GPCR drug discovery, pharmacology, or advanced modeling, there's a course for you. 💡 Bonus: Premium Members enjoy 25% off on all courses! 🔗 Explore & register today: https://www.ecosystem.drgpcr.com/gpcr-courses #GPCR #DrGPCR #Biotech #DrugDiscovery #Pharmacology | Dr. GPCR Ecosystem
🚀 Whether you're diving into GPCR drug discovery, pharmacology, or advanced modeling, there's a course 🚀 Whether you're diving into GPCR drug discovery, pharmacology, or advanced modeling, there's a course
- Dr. Demet Araç | Dr. GPCR Ecosystem
gain domain of adhesion GPCRs started during his postdoctoral studies and continued into his faculty position
- Dr. Lukas Grätz | Dr. GPCR Ecosystem
My initial focus was on creating an automated chimeric homology modeling pipeline for GPCRs and since
- Dr. Paul Insel | Dr. GPCR Ecosystem
studied receptor function in human physiology, receptor molecular pharmacology in cells, and animal models
- Gáspár Pándy-Szekeres | Dr. GPCR Ecosystem
My initial focus was on creating an automated chimeric homology modeling pipeline for GPCRs and since
- Dr. Brian Bender | Dr. GPCR Ecosystem
California in San Francisco to continue his training as a postdoctoral researcher where he used structural models
- Abstract Submission Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Signaling Trafficking Metabolism Structure and Bioinformatics Health and Disease Immunology Nervous system Model
- 💡 GPCR drug development doesn’t have to be a mystery! Learn from Dr. Terry Kenakin in this 4-week immersive course covering ligand development & pharmacology. 🔹 What you’ll learn: ✅ Drug Development Basics – Absorption, metabolism, PK principles ✅ Clearance & Distribution – Renal & hepatic clearance, key pharmacokinetics ✅ PK-PD Modeling – Predicting drug behavior, non-linear PK ✅ Early Drug Safety – Toxicity risks & drug interactions 📌 Spots are filling fast! Sign up today 👉 Development of GPCR Ligands as Therapeutic Drugs | Dr. GPCR Ecosystem #GPCR #DrGPCR #Pharmacology #Biotech #DrugDiscovery | Dr. GPCR Ecosystem
PK principles ✅ Clearance & Distribution – Renal & hepatic clearance, key pharmacokinetics ✅ PK-PD Modeling metabolism, PK principles✅ Clearance & Distribution – Renal & hepatic clearance, key pharmacokinetics✅ PK-PD Modeling
- Dr. Graham Ladds | Dr. GPCR Ecosystem
He continued to work at Warwick as a post-doc studying pro-hormone convertases before securing a 5-year His research group uses a combination of pharmacological investigations and mathematical modeling to
- Dr. Benjamin Myers | Dr. GPCR Ecosystem
transmembrane receptors, combining biochemical and structural approaches with cell biology and in vivo models
- Dr. Kenneth A. Jacobson | Dr. GPCR Ecosystem
He adapts interdisciplinary approaches (synthesis, modeling, pharmacology) to study G protein-coupled
- Developing new tools to uncover GPCR signaling patterns with Remi Janicot | Dr. GPCR Ecosystem
Overall, the lab works on diverse models and diseases, and has developed a wide array of tools to dissect
- Dr. Marta Filizola | Dr. GPCR Ecosystem
computational structural biology tools and rational drug design approaches, ranging from molecular modeling
- Dr. Sai Prasad Pydi | Dr. GPCR Ecosystem
His laboratory uses knock-out and transgenic mouse models, along with different cell culture systems,
- Dr. Nicola J. Smith | Dr. GPCR Ecosystem
the understanding of how an orphan GPCR exerts its effects both in vitro (cell culture and ex vivo models
- Atypical Structure and Function of Typical Chemokine Receptors
laboratory is to understand the physiological consequences of NMDA receptor deficiency using genetic mouse models
- Interaction with the cell adhesion molecule NEGR1 affects mGluR5 cell signalling
Ribeiro has supervised eleven M.Sc. and six Ph.D. students, as well as five post-doctorate fellows. her research group comprises four undergraduates, two M.Sc., and six Ph.D. students, as well as five post-doctorate These drugs were shown to be very effective to rescue the cell death observed in a mouse model of Huntington























